ArticleClinical proteomics2020

Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer.

Dongyoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.